Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elvina Valatkaitė"'
Autor:
Brigita Vaigauskaitė-Mažeikienė, Raminta Baušytė, Elvina Valatkaitė, Rūta Maželytė, Edita Kazėnaitė, Diana Ramašauskaitė, Rūta Navakauskienė
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Background: Unexplained infertility (UI) can be a frustrating and challenging diagnosis for doctors and couples as it can be difficult to understand why they are unable to conceive despite increasing diagnostic tools. Assisted reproductive technology
Externí odkaz:
https://doaj.org/article/66916d1b081c464aa6cf7c848048889a
Autor:
Rūta Navakauskienė, Deimantė Žukauskaitė, Veronika Viktorija Borutinskaitė, Tetiana Bukreieva, Giedrė Skliutė, Elvina Valatkaitė, Aistė Zentelytė, Lina Piešinienė, Volodymyr Shablii
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Cryopreservation of placenta tissue for long-term storage provides the opportunity in the future to isolate mesenchymal stromal cells that could be used for cell therapy and regenerative medicine. Despite being widely used, the established cryopreser
Externí odkaz:
https://doaj.org/article/111110c10cc34dfeb751591847324c1e
Autor:
Elvina Valatkaitė, Raminta Baušytė, Aida Vitkevičienė, Diana Ramašauskaitė, Rūta Navakauskienė
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Human endometrium derived mesenchymal stem cells (hEndSCs) offer a great promise for regenerative medicine and reproductive system disorders treatment methods based on cell therapy due to their broad differentiation potential and highly efficient pro
Externí odkaz:
https://doaj.org/article/31e9fe67e0ac416ca897021d05fe0fc8
Autor:
Brigita Vaigauskaitė, Raminta Baušytė, Elvina Valatkaitė, Giedrė Skliutė, Edita Kazėnaitė, Diana Ramašauskaitė, Rūta Navakauskienė
Publikováno v:
Medicina, Vol 58, Iss 4, p 498 (2022)
Background and objectives. Gestational diabetes mellitus is an increasingly diagnosed metabolic disorder during pregnancy with unknown pathological pathways. Taking into account the growing numbers of women who are conceiving after assisted reproduct
Externí odkaz:
https://doaj.org/article/9fda4e14931d4f689f73eb07763feac3
Publikováno v:
International Journal of Molecular Sciences
International journal of molecular sciences, Basel : MDPI, 2020, vol. 21, iss. 22, art. no. 8752, p. [1-20]
International Journal of Molecular Sciences, Vol 21, Iss 8752, p 8752 (2020)
Volume 21
Issue 22
International journal of molecular sciences, Basel : MDPI, 2020, vol. 21, iss. 22, art. no. 8752, p. [1-20]
International Journal of Molecular Sciences, Vol 21, Iss 8752, p 8752 (2020)
Volume 21
Issue 22
Human amniotic fluid-derived mesenchymal stem cells (AF-MSCs) may be potentially applied in cell therapy or regenerative medicine as a new alternative source of stem cells. They could be particularly valuable in restoring cardiac tissue after myocard
Publikováno v:
Journal of cellular biochemistryREFERENCES. 121(7)
Human amniotic fluid mesenchymal stem cells (AF-MSCs) are a valuable, easily obtainable alternative source of SCs for regenerative medicine. Usually, amounts of cells required for the translational purposes are large thus the goal of this study was t
Autor:
Raminta Bausyte, Brigita Vaigauskaite - Mazeikiene, Veronika Borutinskaite, Elvina Valatkaite, Justinas Besusparis, Ruta Barbora Valkiuniene, Edita Kazenaite, Diana Ramasauskaite, Ruta Navakauskiene
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Endometrial-factor induced infertility remains one of the most significant pathology among all fertility disorders. Stem cell-based therapy is considered to be the next-generation approach. However, there are still issues about successfully retrievin
Externí odkaz:
https://doaj.org/article/c43acdb0b2d44c2da9a3224ac0f68678